Table of Contents

 

 

              I.      Division Director Memorandum

   Division Director Memorandum Erratum

 

           II.      Salmeterol Postmarketing Study Review (SMART Study)

 

         III.      Formoterol Phase 4 Study Review

 

        IV.      Serevent Diskus Product Label

 

           V.      Advair Diskus Product Label

 

        VI.      Foradil Aerolizer Product Label

 

      VII.      Published Articles